Abstract
The expression of apoptotic factors Bcl-2 and Bax were studied in the conjunctiva of diabetic patients with and without retinopathy. All patients underwent a complete ophthalmic examination including ocular fundus and retinal fluorescein angiography. The indirect immunoperoxidase method was performed on 15 normal conjunctiva taken during cataract surgery (group 1), on 40 eyes of 40 patients with type 2 diabetes without diabetic retinopathy (group 2) and 13 eyes of 13 patients with diabetic retinopathy (group 3). In normal human conjunctiva, Bax showed positive expression in epithelial, vascular and stromal cells whereas Bcl-2 staining was negative. In the conjunctiva of diabetic patients without diabetic retinopathy, Bax was widely, and strongly, expressed in epithelial cells, vascular endothelial cells, fibroblasts and infiltrating cells such as macrophages. For patients with diabetic retinopathy, Bax was consistently strong to very strong. Bcl-2 protein expression became weak to negative for diabetic patients both with and without diabetic retinopathy. Immunoreactivity was not correlated between Bcl-2 and Bax in the conjunctiva of diabetic patients. Bax was always localized in tissues characterized by a high rate of apoptosis, whereas, Bcl-2 was absent. Our results suggest that diabetic human conjunctiva, with its inflammatory phenomena, is considered as a privileged target for programmed cell death.
Similar content being viewed by others
References
Abu El-Asrar AM, Dralands L, Missotten L, Geboes K (2007) Expression of antiapoptotic and proapoptotic molecules in diabetic retinas. Eye 21:238–245
Abu-El-Asrar AM, Dralands L, Missoten L, Al-Jadaan IA, Geboes K (2004) Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 45:2760–2766
Adamis AP (2002) Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 86:363–365
Altannavch TS, Roubalova K, Kucera P, Andel M (2004) Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol Res 53:77–82
Bai-hua C, De-yong J, Luo-sheng T (2006) Advanced glycation end-products induce apoptosis involving the signalling pathways of oxidative stress in bovine retinal pericytes. Life Sci 79:1040–1048
Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783–791
Braunstein SN, White JR (2005) Trends in the management of type 2 diabetes: an emerging role for insulin. J Manag Care Pharm 11:S2–S11
Brignole F, Auzerie O, Baudouin C (2003) Apoptose et surface oculaire. J Fr Ophtalmol 26:299–306
Burmester GR, Pezzutto A (1998) Atlas de poche d’immunologie. Flammarion médecine-sciences, Paris
Camillari-Brote S, Molina T (2000) A quoi sert l'apoptose? Revue Praticien 50:1745–1748
Cullinan AE, Brandt CR (2004) Cytokine induced apoptosis in human retinoblastoma cells. Mol Vision 10:315–322
Daniels JT, Dart JK, Tuft SJ, Khaw PT (2001) Corneal stem cells in press. Wound Repair Regen 9:483–494
Del Poeta G, Venditti A, Del Principe MI (2003) Amount of spontaneous apoptosis detected by bax/bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood 101:2125–2131
Doonan F, Donovan M, Cotter TG (2003) Caspase-independent photoreceptor apoptosis in mouse models of retinal degeneration. J Neurosci 23:5723–5731
Dubois-Dauphin M (2003) Contrôle moléculaire de l’apoptose. J Fr Ophtalmol 26:293–298
Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Klein R (2004) Retinopathy in diabetes. Diabetes Care 27:84–87
Gao C, Wang AY (2009) Significance of increased apoptosis and Bax expression in human small intestinal adenocarcinoma. J Histochem Cytochem 57:1139–1148
Habn P, Lindsten T, Ying GS, Bennett J, Milam AH, Tbompson GB, Dunaief JL (2003) Proapoptic Bcl-2 family members, Bax and Bak, are essential for development photoreceptor apoptosis. Invest Ophthalmol Vis Sci 44:3598–3605
Haddad WM, Coscas G, Soubrane G (2003) Dégénérescence maculaire liée à l’âge et apoptose. J Fr Ophtalmol 26:307–311
Hasnan J, Yusof MI, Damitri TD, Faridah AR, Adenan AS, Norbaini TH (2010) Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singapore Med J 51:50–55
Israels LG, Israels ED (1999) Apoptosis. Oncologist 4:332–339
Jürgen G, Woenckhaus C, Fabian M, Tost F (2005) Age-related differential expression of apoptosis-related genes in conjunctival epithelial cells. Acta Ophthalmol Scand 83:471–476
Kajta M (2004) Apoptosis in the central nervous system mechanisms and protective strategies. Pol J Pharmacol 56:689–700
Khalfaoui T, Beltaief O, Meddeb Amel O (2007) Expression of Bax and Bcl-2 apoptotic factors in the conjunctiva of diabetic patients: a preliminary study. J Fr Ophtalmol 30:799–806
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520–526
Koga M, Hiromatsu Y, Jimi A, Toda S, Koike N, Nonaka K (1999) Immunohistochemical analysis of Bcl-2, Bax, and Bak expression in thyroid glands from patients with subacute thyroiditis. J Clin Endocrinol Metab 84:2221–2225
Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4:327–332
Krajewski S, Krajewaska M, Shabaik A, Miyashita T, Wang HG, Reed JC (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor or Bcl-2. Am J Pathol 145:1323–1336
Kria L, Khalfaoui T, Mkannez G, Beltaief O, Anane R, Errais K, Tounsi L, Zhioua R, Jilani SB, Ouertani AM (2005) Immunohistochemical study of vascular endothelial growth factor (VEGF), tumor suppressor protein (p53) and intercellular adhesion molecule (ICAM-1) in the conjunctiva of diabetic patients. J Mol Histol 36:381–390
Manaviat MR, Afkhami M, Shoja MR (2004) Retinopathy and microalbumineria in type II diabetic patients. BMC Ophthalmol 4:1471–1475
Masao S (2002) Molecular mechanisms of lymphomagenesis through transcriptional disregulation by chromosome translocation. Int J Hematol 76:323–326
Melino G, Annicchiarico-Petruzzelli M, Piredda L, Candi E, Gentile V, Davies PJA, Piacentini M (1994) Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol 14:6584–6596
Mohr S, Xi X, Tang J, Kern TS (2002) Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 51:1172–1179
Murphy KM, Ranganathan V, Farnsworth ML, Kavallaris M, Lock RB (2000) Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ 7:102–111
Noble KE, Wickremasinghe RG, DeCornet C, Panayiotis P, Yong KL (1999) Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. J Immunol 162:1376–1383
Oshitari T, Roy S (2005) Diabetes: a potential enhancer of retinal injury in rat retinas. Neurosci Lett 390:25–30
Podesta F, Romeo G, Liu WH, Krajewski S, Reed JC, Gerhardinger C, Lorenzi M (2000) Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol 156:1025–1032
Reagan-Shaw S, Nihal M, Ahsan H, Mukhtar H, Ahmad N (2008) Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio. Prostate 68:1624–1634
Reed JC (2006) Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ 13:1378–1386
Santos KG, Schneider JR, Souta KEP, Roisenberg I (2005) Prevalence of retinopathy in caucasian type II diabetic patients from the south of Brazil and relationship with clinical and metabolic factors. Braz J Med Biol Res 38:221–225
Sennlaub F, Courtois Y, Goureau O (2002) Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. J Neurosci 22:3987–3993
Shi SR, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741–748
Sophie CB, Molina T (2000) A quoi sert l’apoptose? Revue du praticien 50:1745–1748
Takamura Y, Sugimoto Y, Kubo E, Takahashi Y, Akagi Y (2001) Immunohistochemical study of apoptosis of lens epithelial cells in human and diabetic rat cataracts. Jpn J Ophthalmol 45:559–563
Tan DTH, Tang WY, Liu YP, Goh HS, Smith DR (2000) Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 84:212–216
Tang DG, Porter AT (1996) Apoptosis: a current molecular analysis. Pathol Oncol Res 2:117–131
Tapp RJ, Shaw JE, Harper CA, De Courten MP, Blakau B, MacCarty DJ, Taylor HR, Welborn TA, Zimmet PZ (2003) The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26:1731–1737
Toshiyuki Oshitari, Sayon Roy (2005) Diabetes: A potential enhancer of retinal injury in rat retinas. Neuroscience Letters 390:25–30
Veronica A, Chiara G, Todd H, Abidemi A, Mara L (2003) A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52:506–511
Vorkauf M, Duncker G, Nolle B, Sterry W (1993) Adhesion molecules in normal human conjunctiva. An immunohistological study using monoclonal antibodies. Graefes Arch Clin Exp Ophthalmol 231:323–330
Wassim YA, Ohannes KM, Maroun MAJ (2004) On the link between Bcl-2 family proteins and glucocorticoidinduced apoptosis. J Leukoc Biol 76:7–14
Weinstein O, Rosenthal G, Zirkin H, Monos T, Lifshitz T, Argov S (2002) Overexpression of p53 tumor suppressor gene in pterygia. Eye 16:619–621
Xin-Yuan G, Hong-Yu K, Wei Z, Xiao-Min L, Hong-Bin L, Yi Y (2009) The timing of re-institution of good blood glucose control affects apoptosis and expression of Bax and Bcl-2 in the retina of diabetic rats. Mol Biol Rep 36:1977–1982
Yam JC, Kwok AKH (2007) Update on the treatment of diabetic retinopathy. Hong Kong Med J 13:46–60
Yamashiro K, Tsujikawa A, Ishida S, Usui T, Kaji Y, Honda Y, Ogura Y, Adamis AP (2003) Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown. Am J Pathol 163:253–259
Yee NS, Pack I, Besmer P (1994) Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice. J Exp Med 179:1777–1787
Yew DT, Sha O, Li WWY, Lam TT, Lorke DE (2001) Proliferation and apoptosis in the epithelium of the developing human cornea and conjunctiva. Life Sci 68:2987–3003
Zhang Y, Herman B (2002) Ageing and apoptosis. Mech Age Dev 123:245–260
Zhang Z, Lapolla SM, Annis MG (2004) Bcl-2 homodimerization involves two distinct binding surfaces, a topographic arrangement that provides an effective mechanism for Bcl-2 to capture activated Bax. J Biol Chem 279:43920–43928
Zhang M, Zhang P, Zhang C, Sun J, Wang L, Li J, Tian Z, Chen W (2009) Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma. J Oral Pathol Med 38:307–313
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khalfaoui, T., Basora, N. & Ouertani-Meddeb, A. Apoptotic factors (Bcl-2 and Bax) and diabetic retinopathy in type 2 diabetes. J Mol Hist 41, 143–152 (2010). https://doi.org/10.1007/s10735-010-9271-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-010-9271-9